| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000044268 |
| Receipt No. | R000050557 |
| Scientific Title | Long-term clinical results of posterior chamber type intraocular lens with through hole |
| Date of disclosure of the study information | 2021/05/19 |
| Last modified on | 2021/05/19 (Ver. 1) |
| Basic information | ||
| Public title | Long-term clinical results of posterior chamber type intraocular lens with through hole | |
| Acronym | Hole ICL long-term results | |
| Scientific Title | Long-term clinical results of posterior chamber type intraocular lens with through hole | |
| Scientific Title:Acronym | Hole ICL long-term results | |
| Region |
|
|
| Condition | ||
| Condition | Refractive error | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We report the long-term postoperative results of a posterior tufted intraocular lens with a through hole (KS-AquaPORT, STAAR Surgical). |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Naked eyes,corrected vision, safety, effectiveness, predictability, stability, eye pressure, corneal endothelial cell density, axial length, comorbidities |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Myopic astigmatism | |||
| Key exclusion criteria | none | |||
| Target sample size | 206 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kitasato university Hospital | ||||||
| Division name | Ophthalmogogy | ||||||
| Zip code | 2520375 | ||||||
| Address | 1-15-1, Kitasato,Sagamihara-shi,Kanagawa | ||||||
| TEL | 0427788111 | ||||||
| zavide96@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kitasato university Hospital | ||||||
| Division name | Ophthalmogogy | ||||||
| Zip code | 2520375 | ||||||
| Address | 1-15-1, Kitasato,Sagamihara-shi,Kanagawa | ||||||
| TEL | 0427788111 | ||||||
| Homepage URL | |||||||
| zavide96@gmail.com | |||||||
| Sponsor | |
| Institute | Kitasato university Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kitasato university |
| Address | 1-15-1, Kitasato,Sagamihara-shi,Kanagawa |
| Tel | 0427788111 |
| zavide96@umin.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 206 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | For myopic astigmatism, KS-AquaPORT was inserted at a related facility, and the long-term follow-up of 206 cases was 376 eyes (mean 35.0years, 93 males, 113 females). The preoperative equivalent sphere value was -7.86. Naked eye / corrected visual acuity, safety, efficacy, predictability, stability, intraocular pressure, corneal endothelial cell density, axial length, and complications were evaluated at 2, 4, 6 and 8 years after surgery. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050557 |